-- Piramal Pharma (NSE:PPLPHARMA, BOM:543635) swung to an attributable consolidated loss of 88.2 million Indian rupees in the fiscal fourth quarter ended March 31 from a profit of 1.54 billion rupees a year ago.
Loss per share came in at 0.07 rupees from earnings per share of 1.16 rupees a year earlier, the pharmaceutical company said in a filing to the Indian stock exchanges on Tuesday.
Revenue from operations in fiscal Q4 stood at 27.5 billion rupees, almost unchanged from a year ago.
Shares of the company fell nearly 1% in recent trade.